MedTrace Logo

Feasibility Trial of ValenTx Endo Bypass System of the ValenTx Endo Bypass System in Obese Subjects

NCT01207830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-03-17

No results posted yet for this study

Summary

The purpose of this study is to provide initial clinical data to support the feasibility of use of the ValenTx Endo Bypass system in enhancing weight loss and co-morbidity resolution in morbidly obese subjects

Conditions

Interventions

DEVICE

Endo Bypass System

Subject is implanted with the device for up to 3 years.

Sponsors & Collaborators

  • ValenTx, Inc.

    lead INDUSTRY

Principal Investigators

  • Roberto Rumbaut, M.D. · Hospital San Jose Tec

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-02-28
Completion
2012-02-29

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207830 on ClinicalTrials.gov